The purpose of incorporating this new entity is to expand the company’s pharmaceutical products business in USA.
The company has subscribed to a share capital of $10,000 divided into 10,000 shares with a nominal value of $1 each.
Aurobindo Pharma is an integrated global pharmaceutical company headquartered in Hyderabad, India. The company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries.
The company’s consolidated net profit fell 0.6% to Rs 903.47 crore despite a 11.9% jump in net sales to Rs 8,381.12 crore in Q4 FY25 over Q4 FY24.
The scrip declined 0.38% to end at Rs 1,150.65 on the BSE.